Intensity of warfarin coagulation in the antiphospholipid syndrome

被引：8
|
作者：
Crowther M.A. [1 ]
机构：
[1] Division of Hematology and Thromboembolism, McMaster University, St Joseph's Hospital, 50 Charlton Ave, East Hamilton, ON
来源：
Current Rheumatology Reports | 2010年 / 12卷 / 1期
关键词：
Anticoagulation; Antiphospholipid syndrome; Lupus anticoagulant; Warfarin;
D O I：
10.1007/s11926-009-0070-9
中图分类号：
学科分类号：
摘要：
Antiphospholipid syndrome is a condition with an increased propensity for both arterial and venous thrombosis. Compared with the normal population there is also a higher rate of recurrence. Most evidence exists for the use of warfarin in the secondary prevention of thromboembolism, aiming for an international normalized ratio between 2.0 and 3.0. Care must be taken with all anticoagulants because of the increased risk of bleeding. Several other strategies are available if warfarin fails, including the addition of aspirin, increasing the warfarin target range, and use of heparin. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：64 / 69
页数：5
相关论文
共 50 条
  • [11] Warfarin withdrawalCatastrophic antiphospholipid syndrome: case report
    Reactions Weekly, 2014, 1499 (1) : 33 - 33
  • [12] Warfarin Monitoring in Antiphospholipid Syndrome and Lupus Anticoagulant
    Crowl, Ashley
    Schullo-Feulner, Anne
    Moon, Jean Y.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (11) : 1479 - 1483
  • [13] Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study
    Galli, Monica
    Borrelli, Giovanna
    Jacobsen, Eva Marie
    Marfisi, Rosa Maria
    Finazzi, Guido
    Marchioli, Roberto
    Wisloff, Finn
    Marziali, Stefana
    Morboeuf, Olivier
    Barbui, Tiziano
    BLOOD, 2007, 110 (04) : 1178 - 1183
  • [14] Catastrophic antiphospholipid syndrome on switching from warfarin to rivaroxaban
    Crowley, Maeve P.
    Cuadrado, Maria J.
    Hunt, Beverley J.
    THROMBOSIS RESEARCH, 2017, 153 : 37 - 39
  • [15] RENAL TRANSPLANTATION FOR ANTIPHOSPHOLIPID SYNDROME WITHOUT REVERSAL OF WARFARIN
    Baer, R.
    Mudge, D. W.
    Campbell, S. B.
    Ray, M.
    NEPHROLOGY, 2009, 14 : A54 - A54
  • [16] Warfarin resistance in a patient affected by antiphospholipid antibody syndrome
    Vandelli, MR
    Poli, N
    DeMicheli, E
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2883 - P2883
  • [17] Warfarin in Antiphospholipid syndrome - Time to explore new horizons
    Erkan, D
    Ortel, TL
    Lockshin, MD
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (02) : 208 - 212
  • [18] Thromboelastography in the Characterization of Coagulation Status in Antiphospholipid Syndrome
    Wallace, Natalie H.
    Dumont, Anne
    Burns, Adrienne
    Christopher, Tormey A.
    Rinder, Henry M.
    Kriegel, Martin A.
    Buckley, Lenore M.
    Erkan, Doruk
    Lee, Alfred I.
    BLOOD, 2016, 128 (22)
  • [19] Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome
    Talmadge, DB
    Spyropoulos, AC
    PHARMACOTHERAPY, 2003, 23 (05): : 674 - 677
  • [20] A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding
    Lim, William
    Kaur, Amandeep
    Kenne, Foma Munoh
    Shulimovich, Maxim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
12345